Wogonin Reverses Cisplatin Resistance of Non‐Small Cell Lung Cancer by Inducing Ferroptosis and Disrupting Mitochondrial Quality Control: A Potential Role of the HO ‐1/ PPARγ / PGC ‐1α Axis

Cisplatin resistance remains a major challenge in non-small cell lung cancer (NSCLC) therapy. This study investigated whether wogonin, a natural flavonoid, can reverse cisplatin resistance and explored the underlying mechanisms. The effects of wogonin alone and in combination with cisplatin (DDP) were evaluated in DDP-sensitive (A549) and DDP-resistant (A549/DDP) NSCLC cells using CCK-8, colony formation, wound healing, and Transwell assays. Cell death was characterized by measuring ferroptosis markers (ROS, MDA, GSH, JC-1). Potential targets were identified via RNA sequencing and validated by molecular docking and dynamics simulations. The involvement of the HO-1/PPARγ/PGC-1α axis and mitochondrial quality control was assessed using immunofluorescence, western blotting, qPCR, and electron microscopy, with Zinc Protoporphyrin as an HO-1 inhibitor. In vivo efficacy was confirmed in an NCI-H1975 xenograft model. Wogonin synergized with DDP to inhibit proliferation, migration, and invasion of A549/DDP cells. The combination synergistically induced ferroptosis, characterized by elevated ROS and MDA, depleted GSH, and downregulated SLC7A11. GPX4 was not examined in the current dataset and will be included in follow-up studies. Transcriptomic and in silico analyses identified HO-1, PPARγ, PGC-1α, and SLC7A11 as potential targets. Functionally, the combination suppressed the HO-1/PPARγ/PGC-1α axis and SLC7A11; pharmacological HO-1 inhibition with ZnPP partially reversed these changes. No genetic causality is claimed. Mechanistically, it disrupted mitochondrial quality control by inhibiting biogenesis (reduced mtDNA transcripts, Nrf1/2) and blocking protective mitophagy (altered LC3B localization, reduced Parkin, accumulated p62). In vivo, the combination potently suppressed tumor growth and downregulated the HO-1/PPARγ/PGC-1α axis. These findings suggest that wogonin may reverse cisplatin resistance in NSCLC by inducing ferroptosis and disrupting mitochondrial quality control, potentially through the HO-1/PPARγ/PGC-1α axis. This axis should be considered a working hypothesis pending genetic validation.

Authors

Institutions

Publication Details

Journal
Phytotherapy Research
Published
2026-11-16
DOI
https://doi.org/10.1002/ptr.70527
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Wogonin Reverses Cisplatin Resistance of Non‐Small Cell Lung Cancer by Inducing Ferroptosis and Disrupting Mitochondrial Quality Control: A Potential Role of the HO ‐1/ PPARγ / PGC ‐1α Axis

Zicheng Liang, Mengjuan Tao, Tan Xiaoning, Xiayi Fang
Phytotherapy Research
Ferroptosis and cancer prognosis
article

Wogonin Reverses Cisplatin Resistance of Non‐Small Cell Lung Cancer by Inducing Ferroptosis and Disrupting Mitochondrial Quality Control: A Potential Role of the HO ‐1/ PPARγ / PGC ‐1α Axis

Zicheng Liang, Mengjuan Tao, Tan Xiaoning, Xiayi Fang
article en

Abstract

Cisplatin resistance remains a major challenge in non-small cell lung cancer (NSCLC) therapy. This study investigated whether wogonin, a natural flavonoid, can reverse cisplatin resistance and explored the underlying mechanisms. The effects of wogonin alone and in combination with cisplatin (DDP) were evaluated in DDP-sensitive (A549) and DDP-resistant (A549/DDP) NSCLC cells using CCK-8, colony formation, wound healing, and Transwell assays. Cell death was characterized by measuring ferroptosis markers (ROS, MDA, GSH, JC-1). Potential targets were identified via RNA sequencing and validated by molecular docking and dynamics simulations. The involvement of the HO-1/PPARγ/PGC-1α axis and mitochondrial quality control was assessed using immunofluorescence, western blotting, qPCR, and electron microscopy, with Zinc Protoporphyrin as an HO-1 inhibitor. In vivo efficacy was confirmed in an NCI-H1975 xenograft model. Wogonin synergized with DDP to inhibit proliferation, migration, and invasion of A549/DDP cells. The combination synergistically induced ferroptosis, characterized by elevated ROS and MDA, depleted GSH, and downregulated SLC7A11. GPX4 was not examined in the current dataset and will be included in follow-up studies. Transcriptomic and in silico analyses identified HO-1, PPARγ, PGC-1α, and SLC7A11 as potential targets. Functionally, the combination suppressed the HO-1/PPARγ/PGC-1α axis and SLC7A11; pharmacological HO-1 inhibition with ZnPP partially reversed these changes. No genetic causality is claimed. Mechanistically, it disrupted mitochondrial quality control by inhibiting biogenesis (reduced mtDNA transcripts, Nrf1/2) and blocking protective mitophagy (altered LC3B localization, reduced Parkin, accumulated p62). In vivo, the combination potently suppressed tumor growth and downregulated the HO-1/PPARγ/PGC-1α axis. These findings suggest that wogonin may reverse cisplatin resistance in NSCLC by inducing ferroptosis and disrupting mitochondrial quality control, potentially through the HO-1/PPARγ/PGC-1α axis. This axis should be considered a working hypothesis pending genetic validation.

Phytotherapy Research
Zhejiang Chinese Medical University (CN), Hunan University of Traditional Chinese Medicine (CN), Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine (The Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine) (CN)
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon